4baseCare
Sagar Upadhyay currently serves as a Senior Genome Analyst at 4baseCare since September 2024, following a similar role at MEDGENOME from March 2021 to August 2024. At MEDGENOME, Sagar specialized in the analysis and interpretation of Next Generation Sequencing (NGS) and Sanger sequencing results for patients with leukaemias and lymphomas, utilizing various Illumina sequencing platforms and scientific databases for gene classification and clinical reporting. Sagar has experience in resolving CNVs, validating leukaemia fusion testing, and managing variant databases while supervising junior analysts. Sagar's educational background includes a Master of Science in Medical Genetics and Genomics from the University of Glasgow and a Bachelor of Science in Life Sciences from St. Xavier's College. Prior volunteer experiences include positions at ScienceUtsav and Holy Trinity Church.
This person is not in the org chart
This person is not in any teams
4baseCare
4baseCare, an Illumina-backed Company* headquartered in Singapore, is engaged in developing cutting-edge Precision Oncology Solutions using Advanced Genomics and Next-Gen digital health technology. Taking into consideration that the clinical outcome could significantly vary across different populations, we have developed a unique set of indigenous comprehensive cancer gene panels that enables oncologists to choose the optimal precision therapies for their patients. Our coveted genomic testing portfolio assesses the tumour genomic alterations by NGS from Tissue or Liquid biopsy for Somatic Mutation Analysis and Germline Mutation Testing for Hereditary and Familial Cancer from peripheral blood to personalize patient care in Oncology. *Part of Illumina Accelerator 10th Cycle